3Marques-Vidal P, Arveiler D, Amouyel P, et al. Sex differences in awareness and control of hypertension in France. J Hypertens, 1997,15∶1205-1210.
4Tao SQ, Wu XG, Duan XF, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J,1995,108∶483-489.
5Zhou B, Zhang H, Wu Y, et al. Ecological analysis of the association between incidence and risk factors of coronary heart disease and stroke in Chinese populations. CVD Prevention, 1998, 1∶207-216.
6Arroyo P, Fernandez V, Loria A, et al. Hypertension in urban Mexico: the 1992-93 national survey of chronic diseases. J Hum Hypertens, 1999,13∶671-675.
7Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40∶920-927.
8Vicki LB, Jeffrey AC, Millicent H, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension, 1995, 26∶60-69.
9Joffres MR, Ghadirian P, Fodor JG, et al. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens, 1997,10∶1097-1102.
10Deepa R, Shanthirani CS, Pradeepa R, et al. Is the ‘rule of halves' in hypertension still valid?-evidence from the Chennai urban population study. J Assoc Physicians India, 2003,51∶153-157.
